Abstract
Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system. It is widely accepted that a dysregulated immune response against brain resident antigens is central to its yet unknown pathogenesis1,2,3,4. Although there is evidence that the development of MS has a genetic component, specific genetic factors are largely unknown5,6,7. Here we investigated the role of a point mutation in the gene (PTPRC) encoding protein-tyrosine phosphatase, receptor-type C (also known as CD45) in the heterozygous state in the development of MS. The nucleotide transition in exon 4 of the gene locus interferes with mRNA splicing and results in altered expression of CD45 isoforms on immune cells. In three of four independent case-control studies, we demonstrated an association of the mutation with MS. We found the PTPRC mutation to be linked to and associated with the disease in three MS nuclear families. In one additional family, we found the same variant CD45 phenotype, with an as-yet-unknown origin, among the members affected with MS. Our findings suggest an association of the mutation in PTPRC with the development of MS in some families.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Martin, R., McFarland, H.F. & McFarlin, D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10, 153–187 (1992).
Hafler, D.A. & Weiner, H.L. Immunologic mechanisms and therapy in multiple sclerosis. Immunol. Rev. 144, 75–107 (1995).
Steinman, L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85, 299–302 (1996).
Noseworthy, J.H. Progress in determining the causes and treatment of multiple sclerosis. Nature 399, 40–47 (1999).
Sawcer, S., Goodfellow, P.N. & Compston, A. The genetic analysis of multiple sclerosis. Trends Genet. 13, 234–239 (1997).
Oksenberg, J.R. & Hauser, S.L. New insights into the immunogenetics of multiple sclerosis. Curr. Opin. Neurol. 10, 181–185 (1997).
Ebers, G.C. & Dyment, D.A. Genetics of multiple sclerosis. Semin. Neurol. 18, 295–299 (1998).
Trowbridge, I.S. & Thomas, M.L. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12, 85–116 (1994).
Shenoi, H., Seavitt, J., Zheleznyak, A., Thomas, M.L. & Brown, E.J. Regulation of integrin-mediated T cell adhesion by the transmembrane protein tyrosine phosphatase CD45. J. Immunol. 162, 7120–7127 (1999).
Thomas, M.L. & Brown, E.J. Positive and negative regulation of Src-family membrane kinases by CD45. Immunol. Today 20, 406–411 (1999).
Thomas, M.L. The leukocyte common antigen family. Annu. Rev. Immunol. 7, 339–369 (1989).
Novak, T.J. et al. Isoforms of the transmembrane tyrosine phosphatase CD45 differentially affect T cell recognition. Immunity 1, 109–119 (1994).
Leitenberg, D., Boutin, Y., Lu, D.D. & Bottomly, K. Biochemical association of CD45 with the T cell receptor complex: regulation by CD45 isoform and during T cell activation. Immunity 10, 701–711 (1999).
Kishihara, K. et al. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell 74, 143–156 (1993).
Kung, C. et al. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nature Med. 6, 343–345 (2000).
Schwinzer, R. & Wonigeit, K. Genetically determined lack of CD45R-T cells in healthy individuals. Evidence for a regulatory polymorphism of CD45R antigen expression. J. Exp. Med. 171, 1803–1808 (1990).
Thude, H., Hundrieser, J., Wonigeit, K. & Schwinzer, R. A point mutation in the human CD45 gene associated with defective splicing of exon A. Eur. J. Immunol. 25, 2101–2106 (1995).
Zilch, C.F. et al. A point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans. Eur. J. Immunol. 28, 22–29 (1998).
Martin, E.R., Kaplan, N.L. & Weir, B.S. Tests for linkage and association of nuclear families. Am. J. Hum. Genet. 61, 439–448 (1997).
Haines, J.L. et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nature Genet. 13, 469–471 (1996).
Sawcer, S. et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genet. 13, 464–468 (1996).
Ebers, G.C. et al. A full genome search in multiple sclerosis. Nature Genet. 13, 472–476 (1996).
Kuokkanen, S. et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am. J. Hum. Genet. 61, 1379–1387 (1997).
Poser, C.M. et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13, 227–231 (1983).
Kantarci, O.H., Atkinson, E.J., Hebrink, D.D., McMurray, C.T. & Weinshenker, B.G. A population-based association study of two polymorphisms in the IL-1β and IL-1 receptor antagonist genes with susceptibility to and severity of multiple sclerosis. J. Neuroimmunol. 106, 220–227 (2000).
Vergelli, M. et al. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87–99). Eur. J Immunol. 26, 2624–2634 (1996).
Acknowledgements
We thank S. Cepok, R. Dodel, A. Hehenkamp, M. Happel, R. Holzbach, J. Hundrieser, S. Schumacher, C. Schmid and B. Tackenberg for support, and A. Tzou for comments on the manuscript. The study was supported by the Gemeinnützige Hertie-Stiftung, the Deutsche Forschungsgemeinschaft (SFB 297-B6 and grant Schw437/2) and the Stiftung P.E. Kempkes. O.K., J.S.-K. and B.G.W. were supported by the National Multiple Sclerosis Society of the USA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jacobsen, M., Schweer, D., Ziegler, A. et al. A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat Genet 26, 495–499 (2000). https://doi.org/10.1038/82659
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/82659
This article is cited by
-
Overexpression of CD45RA isoforms in carriers of the C77G mutation leads to hyporeactivity of CD4+CD25highFoxp3+ regulatory T cells
Genes & Immunity (2015)
-
Protein tyrosine phosphatases as potential therapeutic targets
Acta Pharmacologica Sinica (2014)
-
Protein tyrosine phosphatases in lymphocyte activation and autoimmunity
Nature Immunology (2012)
-
The CD45 77C/G allele is not associated with myasthenia gravis - a reassessment of the potential role of CD45 in autoimmunity
BMC Research Notes (2010)
-
Peripheral blood gene expression profiling in Sjögren's syndrome
Genes & Immunity (2009)